BRPI0812250A2 - Composição farmacêutica de liberação lenta feita de micropartículas - Google Patents
Composição farmacêutica de liberação lenta feita de micropartículasInfo
- Publication number
- BRPI0812250A2 BRPI0812250A2 BRPI0812250-4A2A BRPI0812250A BRPI0812250A2 BR PI0812250 A2 BRPI0812250 A2 BR PI0812250A2 BR PI0812250 A BRPI0812250 A BR PI0812250A BR PI0812250 A2 BRPI0812250 A2 BR PI0812250A2
- Authority
- BR
- Brazil
- Prior art keywords
- microparticles
- pharmaceutical composition
- slow release
- release pharmaceutical
- composition made
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07109767.9 | 2007-06-06 | ||
EP07109767 | 2007-06-06 | ||
IB2007054372 | 2007-10-27 | ||
IBPCT/IB2007/054372 | 2007-10-27 | ||
PCT/IB2008/052241 WO2008149320A2 (en) | 2007-06-06 | 2008-06-06 | Slow release pharmaceutical composition made of microparticles |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0812250A2 true BRPI0812250A2 (pt) | 2014-12-23 |
BRPI0812250B1 BRPI0812250B1 (pt) | 2020-03-03 |
BRPI0812250B8 BRPI0812250B8 (pt) | 2021-05-25 |
Family
ID=40032512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0812250A BRPI0812250B8 (pt) | 2007-06-06 | 2008-06-06 | composição farmacêutica de liberação lenta de uma triptorelina agonista de lhrh feita de micropartículas e uso da mesma |
Country Status (32)
Country | Link |
---|---|
US (3) | US10166181B2 (pt) |
EP (3) | EP2500014B1 (pt) |
JP (1) | JP5419169B2 (pt) |
KR (1) | KR101631475B1 (pt) |
CN (1) | CN101677959B (pt) |
AP (1) | AP3000A (pt) |
AU (1) | AU2008259411B2 (pt) |
BR (1) | BRPI0812250B8 (pt) |
CA (1) | CA2688478C (pt) |
CO (1) | CO6251234A2 (pt) |
CY (2) | CY1118434T1 (pt) |
DK (2) | DK2500014T3 (pt) |
EA (1) | EA019284B1 (pt) |
ES (2) | ES2694401T3 (pt) |
HK (1) | HK1141737A1 (pt) |
HR (2) | HRP20161785T1 (pt) |
HU (2) | HUE031550T2 (pt) |
IL (1) | IL202501A (pt) |
LT (2) | LT2164467T (pt) |
MA (1) | MA31422B1 (pt) |
ME (1) | ME00959B (pt) |
MX (1) | MX2009012856A (pt) |
MY (1) | MY150450A (pt) |
NZ (1) | NZ582423A (pt) |
PL (2) | PL2164467T3 (pt) |
PT (2) | PT2500014T (pt) |
RS (2) | RS55591B1 (pt) |
SI (2) | SI2164467T1 (pt) |
TN (1) | TN2009000476A1 (pt) |
UA (1) | UA99830C2 (pt) |
WO (1) | WO2008149320A2 (pt) |
ZA (1) | ZA200907940B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008149320A2 (en) | 2007-06-06 | 2008-12-11 | Debio Recherche Pharmaceutique S.A. | Slow release pharmaceutical composition made of microparticles |
PT105270B (pt) | 2010-08-26 | 2012-05-31 | Domino Ind Ceramicas S A | Camada de sílica com libertação lenta de fragrância, telha cerâmica e respectivo processo de produção |
CN105267153B (zh) * | 2015-11-27 | 2018-05-11 | 上海苏豪逸明制药有限公司 | 一种曲普瑞林缓释微粒及其制备方法 |
CN105797134B (zh) * | 2016-03-29 | 2019-06-14 | 浙江圣兆药物科技股份有限公司 | 一种难溶亮丙瑞林缓释制剂 |
WO2018083633A1 (en) | 2016-11-02 | 2018-05-11 | Debiopharm International, S.A. | Methods for improving anti-cd37 immunoconjugate therapy |
KR102402639B1 (ko) | 2017-11-24 | 2022-05-26 | 삼성전자주식회사 | 전자 장치 및 그의 통신 방법 |
CN111000798B (zh) * | 2019-12-26 | 2021-11-23 | 四川恒博生物科技有限公司 | 一种采用原位凝胶技术的犬用非手术去势注射液 |
IT202000017191A1 (it) | 2020-07-15 | 2022-01-15 | Xbrane Biopharma Ab | Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0190833B1 (en) | 1985-02-07 | 1991-03-27 | Takeda Chemical Industries, Ltd. | Method for producing microcapsule |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
US5225205A (en) * | 1989-07-28 | 1993-07-06 | Debiopharm S.A. | Pharmaceutical composition in the form of microparticles |
CH679207A5 (pt) * | 1989-07-28 | 1992-01-15 | Debiopharm Sa | |
MY107937A (en) | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
CH683149A5 (fr) * | 1991-07-22 | 1994-01-31 | Debio Rech Pharma Sa | Procédé pour la préparation de microsphères en matériau polymère biodégradable. |
FR2693905B1 (fr) * | 1992-07-27 | 1994-09-02 | Rhone Merieux | Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues. |
JP3277342B2 (ja) | 1992-09-02 | 2002-04-22 | 武田薬品工業株式会社 | 徐放性マイクロカプセルの製造法 |
WO1995011008A2 (en) * | 1993-10-22 | 1995-04-27 | Genentech, Inc. | Methods and compositions for microencapsulation of adjuvants |
US5945128A (en) * | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
AR012448A1 (es) * | 1997-04-18 | 2000-10-18 | Ipsen Pharma Biotech | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada |
EP1028746B1 (en) | 1997-11-07 | 2003-02-26 | Chiron Corporation | Method for producing igf-i sustained-release formulations |
TWI284048B (en) * | 2000-01-27 | 2007-07-21 | Zentaris Ag | Compressed microparticles for dry injection |
US20040170665A1 (en) * | 2000-06-02 | 2004-09-02 | Allergan, Inc. | Intravitreal botulinum toxin implant |
US7691412B2 (en) * | 2001-10-10 | 2010-04-06 | Pierre Fabre Medicament | Prolonged release biodegradable microspheres and method for preparing same |
EP1617859A1 (en) | 2003-04-30 | 2006-01-25 | Debiopharm S.A. | Methods and compositions using gonadotropin hormone releasing hormone |
KR100466637B1 (ko) * | 2003-06-26 | 2005-01-13 | 주식회사 펩트론 | 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법 |
FR2865938B1 (fr) * | 2004-02-05 | 2006-06-02 | Sod Conseils Rech Applic | Formulation retard solide comprenant de l'acetate de triptoreline |
ES2492641T3 (es) | 2005-12-22 | 2014-09-10 | Novartis Ag | Formulación de liberación sostenida que comprende octreótida y dos o más polímeros de poliláctida-co-glicólido |
WO2008149320A2 (en) | 2007-06-06 | 2008-12-11 | Debio Recherche Pharmaceutique S.A. | Slow release pharmaceutical composition made of microparticles |
-
2008
- 2008-06-06 WO PCT/IB2008/052241 patent/WO2008149320A2/en active Application Filing
- 2008-06-06 AU AU2008259411A patent/AU2008259411B2/en active Active
- 2008-06-06 HU HUE08763237A patent/HUE031550T2/en unknown
- 2008-06-06 ES ES12172232.6T patent/ES2694401T3/es active Active
- 2008-06-06 UA UAA200913838A patent/UA99830C2/uk unknown
- 2008-06-06 MY MYPI20094886 patent/MY150450A/en unknown
- 2008-06-06 DK DK12172232.6T patent/DK2500014T3/en active
- 2008-06-06 EP EP12172232.6A patent/EP2500014B1/en active Active
- 2008-06-06 AP AP2009005088A patent/AP3000A/xx active
- 2008-06-06 NZ NZ582423A patent/NZ582423A/en unknown
- 2008-06-06 LT LTEP08763237.8T patent/LT2164467T/lt unknown
- 2008-06-06 SI SI200831754A patent/SI2164467T1/sl unknown
- 2008-06-06 PT PT12172232T patent/PT2500014T/pt unknown
- 2008-06-06 JP JP2010510946A patent/JP5419169B2/ja active Active
- 2008-06-06 MX MX2009012856A patent/MX2009012856A/es active IP Right Grant
- 2008-06-06 LT LTEP12172232.6T patent/LT2500014T/lt unknown
- 2008-06-06 SI SI200832014T patent/SI2500014T1/sl unknown
- 2008-06-06 PL PL08763237T patent/PL2164467T3/pl unknown
- 2008-06-06 RS RS20170032A patent/RS55591B1/sr unknown
- 2008-06-06 EP EP18186642.7A patent/EP3431077A1/en active Pending
- 2008-06-06 PL PL12172232T patent/PL2500014T3/pl unknown
- 2008-06-06 RS RS20181349A patent/RS58248B1/sr unknown
- 2008-06-06 BR BRPI0812250A patent/BRPI0812250B8/pt active IP Right Grant
- 2008-06-06 CA CA2688478A patent/CA2688478C/en active Active
- 2008-06-06 KR KR1020107000176A patent/KR101631475B1/ko active IP Right Grant
- 2008-06-06 CN CN200880018833.3A patent/CN101677959B/zh active Active
- 2008-06-06 EP EP08763237.8A patent/EP2164467B1/en not_active Revoked
- 2008-06-06 DK DK08763237.8T patent/DK2164467T3/en active
- 2008-06-06 PT PT87632378T patent/PT2164467T/pt unknown
- 2008-06-06 EA EA200971132A patent/EA019284B1/ru unknown
- 2008-06-06 ES ES08763237.8T patent/ES2611020T3/es active Active
- 2008-06-06 US US12/601,649 patent/US10166181B2/en active Active
- 2008-06-06 HU HUE12172232A patent/HUE040391T2/hu unknown
- 2008-06-06 ME MEP-2009-341A patent/ME00959B/me unknown
-
2009
- 2009-11-09 TN TNP2009000476A patent/TN2009000476A1/fr unknown
- 2009-11-11 ZA ZA200907940A patent/ZA200907940B/xx unknown
- 2009-12-01 MA MA32391A patent/MA31422B1/fr unknown
- 2009-12-02 CO CO09137855A patent/CO6251234A2/es not_active Application Discontinuation
- 2009-12-03 IL IL202501A patent/IL202501A/en active IP Right Grant
-
2010
- 2010-09-02 HK HK10108338.2A patent/HK1141737A1/xx unknown
-
2016
- 2016-12-27 HR HRP20161785TT patent/HRP20161785T1/hr unknown
-
2017
- 2017-01-17 CY CY20171100060T patent/CY1118434T1/el unknown
-
2018
- 2018-11-07 CY CY181101171T patent/CY1120891T1/el unknown
- 2018-11-07 HR HRP20181854TT patent/HRP20181854T1/hr unknown
- 2018-11-15 US US16/192,674 patent/US20190192423A1/en not_active Abandoned
-
2022
- 2022-09-15 US US17/932,621 patent/US20230082575A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2018005I1 (lt) | Farmacinė kompozicija | |
BRPI0919466A2 (pt) | composição farmacêutica para liberação modificada | |
BRPI0909780A2 (pt) | Composições e métodos para liberação de fármaco | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
BRPI1011587A2 (pt) | compostos e composições terapèuticas | |
DK3097925T3 (da) | Farmaceutisk sammensætning | |
BRPI1004940A2 (pt) | composição farmacêutica | |
HRP20181854T1 (hr) | Farmaceutski pripravak sporog oslobađanja pripremljen od mikročestica | |
DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
BRPI1015939A2 (pt) | composição farmacêutica | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
BRPI0912428A2 (pt) | formulação farmacêutica sólida de liberação retardada | |
DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
DK2391351T3 (da) | Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater | |
BR112012003149A2 (pt) | composição farmacêutica | |
BRPI0912171A2 (pt) | composição farmacêutica | |
BRPI0912074A2 (pt) | composto e composição farmacêutica | |
BRPI0921301A2 (pt) | composição farmacêutica | |
BRPI0922623A2 (pt) | comprimido farmacêutico de liberação controlada | |
BRPI0906346A2 (pt) | "composição farmacêutica de liberação prolongada" | |
BRPI0820839A2 (pt) | Composição farmacêutica | |
BRPI0906331A2 (pt) | "composição farmacêutica de liberação prolongada" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: DEBIOPHARM RESEARCH AND MANUFACTURING SA (CH) |
|
B25A | Requested transfer of rights approved |
Owner name: DEBIOPHARM INTERNATIONAL SA (CH) |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/03/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/06/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |